semaglutide and optic neuropathy Incretin Mimetrics - Ozempic, Wegovy, Mouraro - For Metabolic Disease - Diabetes - For Eye Care Semaglutide and Non-arteritic Anterior Ischemic

This comparison is arguably the most important in metabolic medicine heading into 2026, as it pits the two pharmaceutical giants against each other in the competition for the best-in-class obesity treatment

This is due to the longer duration of effect of the long-acting medication compared to short-acting agonists

Many individuals are interested in Retatrutide because of its potential to provide broader metabolic support compared to earlier peptide therapies

1997;273(5):E981E988

In therapy, we look at what those concerns are really about: what they reveal about a persons relationship with their body, with control, and with their own sense of worth